Endothelin receptor antagonist bosentan improves microcirculatory blood flow in splanchnic organs in septic shock

被引:46
|
作者
Krejci, V [1 ]
Hiltebrand, LB
Erni, D
Sigurdsson, GH
机构
[1] Univ Hosp Bern, Inselspital, Dept Anesthesiol, CH-3010 Bern, Switzerland
[2] Univ Hosp Bern, Inselspital, Dept Plast & Reconstruct Surg, CH-3010 Bern, Switzerland
[3] Landspitali Univ Hosp, Dept Anesthesia & Intens Care Med, Reykjavik, Iceland
关键词
sepsis; septic shock; intestine; mucosa; muscularis; liver; kidney; pancreas; microcirculation; endothelin; bosentan; pigs;
D O I
10.1097/00003246-200301000-00031
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective. Splanchnic ischemia is believed to play an important role in the development of multiple organ dysfunction in septic shock. The vasoconstrictor peptide endothelin can produce an intense and sustained splanchnic vasoconstriction and is increased in sepsis. The aim of this investigation was to study the effects of an endothelin antagonist on microcirculatory blood flow in multiple abdominal organs during septic shock. Design. Prospective, controlled animal study. Setting. University-affiliated research laboratory. Subjects. Fifteen anesthetized and mechanically ventilated pigs. Interventions: Septic shock was induced by fecal peritonitis. After 120 mins of sepsis, eight animals received 10 mg/kg bosentan intravenously followed by an intravenous infusion at 5 mg.kg(-1).hr(-1) whereas seven (controls) received isotonic saline. At 240 mins after induction of sepsis both groups received hydroxyethyl starch, 20 mL/kg intravenously, to convert hypodynamic septic shock to hyperdynamic sepsis. Measurements and Main Results. Microcirculatory blood flow was measured simultaneously and continuously in the jejunal muscularis, pancreas, liver, kidney, skeletal muscle, and gastric, jejunal, and colon mucosa by using a multiple-channel laser Doppler flow meter. After 120 mins, all animals had developed signs of hypodynamic sepsis with decreased cardiac index, mean arterial blood pressure, and gastric mucosal pH. Microcirculatory blood flow in the pancreas and liver had decreased by 20% and in the jejunal muscularis by >40% (p <.01) whereas it remained virtually unchanged in the gastric, jejunal, and colonic mucosa. After 240 mins, cardiac index, mean arterial blood pressure, gastric mucosal pH, and microcirculatory blood flow in the gastric mucosa, colon mucosa, jejunal muscularis, and pancreas had all deteriorated in the controls, whereas in the bosentan-treated group, cardiac index and microcirculatory blood flow in the pancreas, gastric, and colon mucosa improved. During hyperdynamic sepsis, cardiac index increased above baseline in both groups but significantly more in the bosentan group. In the control group, microcirculatory flow returned to baseline in most tissues except in skeletal muscle and jejunal muscularis. In the bosentan group, microcirculatory flow returned to or increased above baseline in all tissues except in the muscularis of the jejunum. Conclusions., The endothelin receptor antagonist bosentan significantly improved microcirculatory blood flow in many splanchnic organs and in peripheral tissues during septic shock. The results of this study are consistent with the hypothesis that endothelin plays an important role in the regulation of microcirculatory blood flow in splanchnic as well as in peripheral tissues during, septic shock.
引用
收藏
页码:203 / 210
页数:8
相关论文
共 50 条
  • [31] PROTECTIVE EFFECTS OF NONPEPTIDE ENDOTHELIN RECEPTOR ANTAGONIST BOSENTAN ON MYOCARDIAL ISCHEMIC AND REPERFUSION INJURY IN THE PIG
    WANG, QD
    LI, XS
    LUNDBERG, JM
    PERNOW, J
    CARDIOVASCULAR RESEARCH, 1995, 29 (06) : 805 - 812
  • [32] Improvement of bleomycin-induced pulmonary hypertension and pulmonary fibrosis by the endothelin receptor antagonist Bosentan
    Schroll, Stephan
    Arzt, Michael
    Sebah, Daniela
    Nuechterlein, Martin
    Blumberg, Friedrich
    Pfeifer, Michael
    RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY, 2010, 170 (01) : 32 - 36
  • [33] The endothelin receptor antagonist bosentan restores gut oxygen delivery and reverses intestinal mucosal acidosis in porcine endotoxin shock
    Oldner, A
    Wanecek, M
    Goiny, M
    Weitzberg, E
    Rudehill, A
    Alving, K
    Sollevi, A
    GUT, 1998, 42 (05) : 696 - 702
  • [34] Mixed endothelin receptor antagonism with tezosentan improves intestinal microcirculation in endotoxemic shock
    Andersson, Andreas
    Fenhammar, Johan
    Frithiof, Robert
    Weitzberg, Eddie
    Sollevi, Alf
    Hjelmqvist, Hans
    JOURNAL OF SURGICAL RESEARCH, 2008, 149 (01) : 138 - 147
  • [35] Lactate Clearance in Septic Shock Is Not a Surrogate for Improved Microcirculatory Flow
    Puskarich, Michael A.
    Shapiro, Nathan I.
    Massey, Michael J.
    Kline, Jeffrey A.
    Jones, Alan E.
    ACADEMIC EMERGENCY MEDICINE, 2016, 23 (06) : 690 - 693
  • [36] Amelioration of microcirculatory damage by an endothelin A receptor antagonist in a rat model of reversible acute liver failure
    Palmes, D
    Skawran, S
    Stratmann, U
    Armann, B
    Minin, E
    Herbst, H
    Spiegel, HU
    JOURNAL OF HEPATOLOGY, 2005, 42 (03) : 350 - 357
  • [37] The endothelin receptor antagonist bosentan improves peripheral endothelial function in patients with type 2 diabetes mellitus and microalbuminuria: a randomised trial
    Rafnsson, A.
    Bohm, F.
    Settergren, M.
    Gonon, A.
    Brismar, K.
    Pernow, J.
    DIABETOLOGIA, 2012, 55 (03) : 600 - 607
  • [38] Bosentan, a mixed endothelin receptor antagonist, inhibits superoxide anion-induced pain and inflammation in mice
    Karla G. G. Serafim
    Suelen A. Navarro
    Ana C. Zarpelon
    Felipe A. Pinho-Ribeiro
    Victor Fattori
    Thiago M. Cunha
    Jose C. Alves-Filho
    Fernando Q. Cunha
    Rubia Casagrande
    Waldiceu A. Verri
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2015, 388 : 1211 - 1221
  • [39] Bosentan, a mixed endothelin receptor antagonist, inhibits superoxide anion-induced pain and inflammation in mice
    Serafim, Karla G. G.
    Navarro, Suelen A.
    Zarpelon, Ana C.
    Pinho-Ribeiro, Felipe A.
    Fattori, Victor
    Cunha, Thiago M.
    Alves-Filho, Jose C.
    Cunha, Fernando Q.
    Casagrande, Rubia
    Verri, Waldiceu A., Jr.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2015, 388 (11) : 1211 - 1221
  • [40] The endothelin receptor antagonist bosentan improves peripheral endothelial function in patients with type 2 diabetes mellitus and microalbuminuria: a randomised trial
    A. Rafnsson
    F. Böhm
    M. Settergren
    A. Gonon
    K. Brismar
    J. Pernow
    Diabetologia, 2012, 55 : 600 - 607